Autor: |
Naranjo Á; Departamento de Biología Experimental, Universidad de Jaén, 23071 Jaén, Spain., Álvarez-Soria MJ; Servicio de Neurología, Hospital Universitario de Jaén, 23009 Jaén, Spain., Aranda-Villalobos P; UGC Medicina Física y Rehabilitación, Hospital Universitario de Jaén, 23009 Jaén, Spain., Martínez-Rodríguez AM; Departamento de Estadística e Investigación Operativa, Universidad de Jaén, 23071 Jaén, Spain., Martínez-Lara E; Departamento de Biología Experimental, Universidad de Jaén, 23071 Jaén, Spain., Siles E; Departamento de Biología Experimental, Universidad de Jaén, 23071 Jaén, Spain. |
Jazyk: |
angličtina |
Zdroj: |
International journal of molecular sciences [Int J Mol Sci] 2024 Apr 27; Vol. 25 (9). Date of Electronic Publication: 2024 Apr 27. |
DOI: |
10.3390/ijms25094799 |
Abstrakt: |
Hydroxytyrosol (HT) is a bioactive olive oil phenol with beneficial effects in a number of pathological situations. We have previously demonstrated that an HT-enriched diet could serve as a beneficial therapeutic approach to attenuate ischemic-stroke-associated damage in mice. Our exploratory pilot study examined this effect in humans. Particularly, a nutritional supplement containing 15 mg of HT/day was administered to patients 24 h after the onset of stroke, for 45 days. Biochemical and oxidative-stress-related parameters, blood pressure levels, serum proteome, and neurological and functional outcomes were evaluated at 45 and 90 days and compared to a control group. The main findings were that the daily administration of HT after stroke could: (i) favor the decrease in the percentage of glycated hemoglobin and diastolic blood pressure, (ii) control the increase in nitric oxide and exert a plausible protective effect in oxidative stress, (iii) modulate the evolution of the serum proteome and, particularly, the expression of apolipoproteins, and (iv) be beneficial for certain neurological and functional outcomes. Although a larger trial is necessary, this study suggests that HT could be a beneficial nutritional complement in the management of human stroke. |
Databáze: |
MEDLINE |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|